If you’re a regular reader of agebuzz, you know that we have urged you to consider getting inoculated against shingles, an affliction that’s not only painful but could have long term implications for nerve damage, vision or hearing loss and even higher risk of stroke or heart attack. Those are serious concerns- but now for the good news. The FDA has just approved a brand new vaccine for shingles- one that is much more effective than what is currently available. This new vaccine, manufactured by GlaxoSmithKline, offers 98% protection against shingles during the first year after inoculation, and even 3 years later, it continues to offer at least 85% protection. Zostavax, the currently available vaccine, seems to wane quickly in its protection, so this new development offers a real advance. Given that one million people every year are afflicted with shingles, and those with weakened immune systems from age or illness are particularly vulnerable, this feels like a real shot in the arm in the fight against shingles. To find out more, Click Here.